COLLPLANT BIOTECHNOLOGIES LT (CLGN) Stock Price, Forecast & Analysis

NASDAQ:CLGN • IL0004960188

0.63 USD
+0.01 (+1.61%)
Last: Feb 23, 2026, 09:37 AM

CLGN Key Statistics, Chart & Performance

Key Statistics
Market Cap8.05M
Revenue(TTM)2.48M
Net Income(TTM)-12.16M
Shares12.78M
Float8.97M
52 Week High4.98
52 Week Low0.55
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-1.02
PEN/A
Fwd PEN/A
Earnings (Next)03-24
IPO1993-09-01
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
CLGN short term performance overview.The bars show the price performance of CLGN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

CLGN long term performance overview.The bars show the price performance of CLGN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of CLGN is 0.63 USD. In the past month the price decreased by -59.75%. In the past year, price decreased by -82.25%.

COLLPLANT BIOTECHNOLOGIES LT / CLGN Daily stock chart

CLGN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
CLGN Full Technical Analysis Report

CLGN Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CLGN. While CLGN seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CLGN Full Fundamental Analysis Report

CLGN Financial Highlights

Over the last trailing twelve months CLGN reported a non-GAAP Earnings per Share(EPS) of -1.02. The EPS increased by 25% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -86.31%
ROE -130.68%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%28.95%
Sales Q2Q%1825%
EPS 1Y (TTM)25%
Revenue 1Y (TTM)280.77%
CLGN financials

CLGN Forecast & Estimates

8 analysts have analysed CLGN and the average price target is 11.73 USD. This implies a price increase of 1761.9% is expected in the next year compared to the current price of 0.63.

For the next year, analysts expect an EPS growth of 77.99% and a revenue growth 422.12% for CLGN


Analysts
Analysts82.5
Price Target11.73 (1761.9%)
EPS Next Y77.99%
Revenue Next Year422.12%
CLGN Analyst EstimatesCLGN Analyst Ratings

CLGN Ownership

Ownership
Inst Owners14.25%
Ins Owners29.81%
Short Float %1.23%
Short Ratio1.48
CLGN Ownership

CLGN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABBV ABBVIE INC15.81397.325B
AMGN AMGEN INC16.84201.795B
GILD GILEAD SCIENCES INC17.05187.839B
VRTX VERTEX PHARMACEUTICALS INC23.6120.999B
REGN REGENERON PHARMACEUTICALS16.9882.427B
ALNY ALNYLAM PHARMACEUTICALS INC50.7744.414B
INSM INSMED INC N/A35.17B
NTRA NATERA INC N/A29.514B
BIIB BIOGEN INC12.828.182B
UTHR UNITED THERAPEUTICS CORP16.0220.385B

About CLGN

Company Profile

CLGN logo image CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Company Info

COLLPLANT BIOTECHNOLOGIES LT

4 Oppenheimer Street, P.O. Box 4132

Rehovot 7670104 IL

CEO: Yehiel Tal

Employees: 57

CLGN Company Website

CLGN Investor Relations

Phone: 972732325600

COLLPLANT BIOTECHNOLOGIES LT / CLGN FAQ

What does CLGN do?

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).


What is the current price of CLGN stock?

The current stock price of CLGN is 0.63 USD. The price increased by 1.61% in the last trading session.


What is the dividend status of COLLPLANT BIOTECHNOLOGIES LT?

CLGN does not pay a dividend.


What is the ChartMill technical and fundamental rating of CLGN stock?

CLGN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the employee count for CLGN stock?

COLLPLANT BIOTECHNOLOGIES LT (CLGN) currently has 57 employees.


What is the market capitalization of CLGN stock?

COLLPLANT BIOTECHNOLOGIES LT (CLGN) has a market capitalization of 8.05M USD. This makes CLGN a Nano Cap stock.


Can you provide the short interest for CLGN stock?

The outstanding short interest for COLLPLANT BIOTECHNOLOGIES LT (CLGN) is 1.23% of its float.